$PG

Barclays Sticks to Their Hold Rating for Procter & Gamble (PG)

Barclays analyst Lauren Lieberman maintained a Hold rating on Procter & Gamble (PG) with a $152.00 price target. TD Cowen also kept a Hold rating with a $150.00 target. PG reported Q2 revenue of $21.2B and net profit of $3B, down from $3.62B last year. Insider sentiment is negative, with recent sales by executives.

Original reporting
Published Sep 12, 2026, 9:26 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 12, 2026, 6:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Barclays Sticks to Their Hold Rating for Procter & Gamble (PG) — source image
Decision brief

The 30-second read

$PGNeutralLow
01

Why it matters

The reaffirmation of Hold and modest insider sell provide limited new information for traders.

02

Market read

Routine rating reaffirmation and small insider sale; minimal impact on PG price.

03

What to watch

Potential upcoming product launches or cost initiatives not covered in this brief.

Relevance 4/10Novelty 2/10Timing: today

Background

Barclays analyst Lauren Lieberman covers Consumer Defensive stocks and reaffirmed a Hold stance on PG with a $152 price target. TD Cowen also held its rating.

Company-level read

Ticker impact

$PGNeutralMedium confidence
Context

Barclays maintained a Hold rating on Procter & Gamble and reported an insider sale of 3,053 shares worth $438,990.87.

Expected impact

Minor downward pressure, likely within normal volatility range.

Evidence & confidence

No change in rating or target, and insider sale size is small relative to market cap; limited trading impact.

Market effects

None significant for Consumer Staples sector.

Limited to US market where PG trades.

Low; PG is a large cap but news is routine.

Counterpoint

The hold rating may be undervalued if earnings beat expectations later.

Key entities

  • Barclays

    Maintained Hold rating on PG.

  • Lauren Lieberman

    Barclays analyst covering PG.

  • Moses Victor Javier Aguilar

    PG Chief Research, Development & Innovation Officer who sold shares.

Related articles

$PGMed

P&G Is Betting $3.8 Billion on Wellness. Can It Offset a $1 Billion Cost Headwind?

Procter & Gamble (PG) reported fiscal 2026 organic sales growth of 1% and core EPS of $6.89. For fiscal 2027, PG guided organic sales growth of 1% to 3% and core EPS growth of 0% to 3%, citing a $1 billion cost headwind from higher raw materials, energy, and transportation costs. PG acquired Thorne, a premium supplements brand, to offset some pressure. Analysts estimate a target price of $180, implying 22.7% upside over 2.8 years. PG's performance is compared to peers like Colgate-Palmolive (CL)

$PGLow

Procter & Gamble Margins Under Pressure: Time to Stay Cautious?

Procter & Gamble (PG) faces margin pressure from rising costs, expecting a $1.4B after-tax earnings headwind in fiscal 2027. Despite productivity initiatives, Q1 EPS is forecast to decline 5%. Competitors Colgate-Palmolive (CL) and Clorox (CLX) are also implementing cost-saving measures. PG's stock is up 1.7% in 3 months, trading at a forward P/E of 20.72X.

$PGMed

Weather Dividend Stocks That Keep Writing Bigger Checks

Procter & Gamble (PG) raised its dividend for 70 consecutive years, with fiscal 2026 free cash flow of $15.835B. Coca-Cola (KO) reported 5% unit case volume growth, its strongest in 17 years. Colgate-Palmolive (CL) saw 16.12% YTD stock growth and raised its dividend. All three companies demonstrated recession-resilient cash flows and dividend increases.

$PGMed

Toilet paper becomes an issue for Trump again as Canada's tariffs could spell another shortage

Canada imposed 25-50% tariffs on U.S. paper products, including toilet paper, in response to U.S. tariffs on Canadian goods. Procter & Gamble (P&G) expects a $0.25-per-share earnings hit and plans price increases. Canada supplied $328M of toilet paper to the U.S. in 2024, with Canadian pulp crucial for U.S. production. U.S. consumers bear 96% of tariff costs, per Fed research.

$PGMed

Procter & Gamble outlook raised to positive by Moody’s on cash flow

Moody’s affirmed Procter & Gamble’s (PG) ratings and changed the outlook to positive, citing strong cash flow, earnings growth, and stable credit metrics. The upgrade reflects P&G’s ability to generate positive free cash flow and earnings growth through pricing, innovation, and cost savings. Moody’s expects leverage to rise slightly due to the Thorne acquisition but return to low levels through optimization. The ratings could be upgraded if P&G maintains its strong operating profile and profitab